Paxlovid Not on China’s Reimbursement List

January 10th, 2023|Categories: Featured, Industry News|Tags: , , , , |

As the nation phases out its zero-COVID strategy following major protests, China’s National Healthcare Security Administration has left Pfizer’s Paxlovid off its reimbursement list. This comes as cases spike in the nation, with many patients purchasing the drug off the internet through India. However, other COVID drugs did make the cut.

Go to Top